Clinically Apparent Atrial Fibrillation Increases Stroke Risk; Does Subclinical AFib Do the Same?

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Stuart J. Connelly, MD, one of the principal authors of “Subclinical Atrial Fibrillation and the Risk of Stroke,” published in the New England Journal of Medicine, talks about the study.  

To listen to the podcast, click here.
Related Articles
Providing prescriptions when patients are discharged from the hospital after a stroke improves medication adherence, the results of a study suggest.
Several new anticoagulants have entered the US market in recent years, but research to find reversal agents for these drugs is ongoing.
Hospitalization rates for heart disease and stroke have dropped significantly over the past decade.
Digoxin increases risk of death in patients with newly diagnosed atrial fibrillation.
Latest Issues
$auto_registration$